Sharpe ratio is not yet available for MPMCX. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.
How it compares to other similar mutual funds
The table compares BNY Mellon Mid Cap Multi-Strategy Fund's Sharpe Ratio with other mutual funds in the Mid Cap Growth Equities category across multiple time periods, showing how MPMCX's risk-adjusted performance compares to similar funds.
Data shows 1-, 5-, and 10-year periods, plus each fund's all-time average, as of Jul 18, 2026.
| Symbol | Name | 1Y Sharpe Ratio | 5Y Sharpe Ratio | 10Y Sharpe Ratio | All Time Sharpe Ratio |
|---|---|---|---|---|---|
| VHCOX | Vanguard Capital Opportunity Fund Investor Shares | 2.16 | |||
| POAGX | PrimeCap Odyssey Aggressive Growth Fund | 1.92 | |||
| NEEIX | Needham Growth Fund Institutional Class | 1.88 | |||
| NEEGX | Needham Growth Fund | 1.86 | |||
| TAAGX | Timothy Plan Aggressive Growth Fund | 1.82 | |||
| MGOYX | Victory Munder Mid-Cap Core Growth Fund | 1.76 | |||
| ETILX | Eventide Gilead Class I | 1.73 | |||
| ETGLX | Eventide Gilead Fund | 1.71 | |||
| USMIX | USAA Extended Market Index Fund | 1.57 | |||
| CTIGX | Calamos Timpani SMID Growth Fund | 1.52 | |||
| MPMCX | BNY Mellon Mid Cap Multi-Strategy Fund | — |
Loading charts...
How does MPMCX fit in your portfolio?
Add your other holdings to see your portfolio's Sharpe Ratio and find out.
Analyze Your Portfolio